Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00475891 · ClinicalTrials.gov registry record
Determination of Genetic Relatedness of Linezolid-resistant Vancomycin-resistant Enterococci (VRE) Surveillance Cultures
A clinical trial of Isolate and Linezolid, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT00475891 is a study of Isolate and Linezolid that has completed, run by University of Pittsburgh. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00475891, a study of Isolate and Linezolid, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will help in identifying the best empiric antibiotic option for Linezolid resistant Vancomycin-resistant Enterococci (VRE) infections. This research is important because it allows the determination of resistance rates to antibiotics that may not be frequently tested to by the clinical microbiology laboratory at UPMC-Presbyterian. It also will provide antibiotic minimum inhibitory concentrations (MICs) for these pathogens which may help in identifying the best empiric antibiotic option for Linezolid-resistant VRE infections.
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-04 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00475891
The ClinicalTrials.gov registry entry for NCT00475891 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Isolate appearing as the primary indexed condition, and to 0 interventions.
NCT00475891 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00475891 about?
NCT00475891 is a clinical study titled "Determination of Genetic Relatedness of Linezolid-resistant Vancomycin-resistant Enterococci (VRE) Surveillance Cultures". The study will help in identifying the best empiric antibiotic option for Linezolid resistant Vancomycin-resistant Enterococci (VRE) infections. This research is important because it allows the determination of resistance rates to antibiotics that may not be frequently tested to by the clinical micr...
What is the current status of trial NCT00475891?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2007-04. Estimated completion is 2014-12.
What conditions does trial NCT00475891 study?
This clinical trial studies the following conditions: Isolate, Linezolid.
Who is sponsoring clinical trial NCT00475891?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00475891 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.